Vitrolife Forecast, price target & analysts
Vitrolife Target price 2026 - Analyst rating & recommendation
Vitrolife Classifications & Recommendation
Vitrolife Price Target
| Target Price | kr132.60 |
| Price | kr91.80 |
| Potential |
44.44%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Vitrolife 2027 .
The average Vitrolife target price is kr132.60.
This is
44.44%
register free of charge
kr162.75
77.29%
register free of charge
kr101.00
10.02%
register free of charge
|
|
| A rating was issued by 11 analysts: 8 Analysts recommend Vitrolife to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Vitrolife stock has an average upside potential 2027 of
44.44%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 3.44 | 3.52 |
| 4.68% | 2.44% | |
| EBITDA Margin | 24.04% | 32.29% |
| 17.84% | 34.31% | |
| Net Margin | -145.70% | 14.07% |
| 1,125.00% | 109.66% |
8 Analysts have issued a sales forecast Vitrolife 2026 . The average Vitrolife sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Vitrolife EBITDA forecast 2026. The average Vitrolife EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Vitrolife Analysts have issued a net profit forecast 2026. The average Vitrolife net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | -37.01 | 3.66 |
| 1,076.52% | 109.89% | |
| P/E | 25.07 | |
| EV/Sales | 3.79 |
7 Analysts have issued a Vitrolife forecast for earnings per share. The average Vitrolife EPS is
This results in the following potential growth metrics and future valuations:
Current Vitrolife Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Jul 20 2026 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 17 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 17 2026 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jun 30 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Jun 29 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Jul 20 2026 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 17 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 17 2026 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 07 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jun 30 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Jun 29 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
